{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:54:52Z","timestamp":1790650492138,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Abnormalities of the immune system are rarely reported in patients affected by RASopathies. Aim of the current study was to investigate the prevalence of immune system dysfunction in a cohort of patients affected by RASopathies.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study design<\/jats:title>\n                <jats:p>A group of 69 patients was enrolled: 60 at the Federico II University, Naples, 7 at University Magna Graecia of Catanzaro, 2 at \u201cScuola Medica Salernitana\u201d, Salerno. An age- and sex-matched control group was also enrolled. Autoimmune disorders were investigated according to international consensus criteria. Immune framework was also evaluated by immunoglobulin levels, CD3, CD4, CD8, CD19, CD56 lymphocyte subpopulations, autoantibodies levels and panel of inflammatory molecules, in both patients and controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Frequent upper respiratory tract infections were recorded in 2 patients; pneumonia, psoriasis and alopecia in single patients. Low IgA levels were detected in 8\/44 patients (18.18%), low CD8 T cells in 13\/35 patients (37.14%). Anti-tg and anti-TPO antibodies were detected in 3\/24 patients (12.5%), anti r-TSH in 2 cases (8.33%), all in euthyroidism. Serum IgA and CD8 levels were significantly lower in patients than in controls (p 0.00685; p 0.000656 respectively). All tested patients showed increased inflammatory molecules compared to controls. These findings may anticipate the detection of overt autoimmune disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients affected by RASopathies are at risk to develop autoimmune disorders. Routine screening for autoimmunity is recommended in patients with RASopathy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-02050-6","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T14:45:42Z","timestamp":1633358742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity"],"prefix":"10.1186","volume":"16","author":[{"given":"M. A.","family":"Siano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Di Candia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Alessio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"De Brasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sestito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Concolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Strisciuglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"D\u2019Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cabaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Perruolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Formisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9458-3926","authenticated-orcid":false,"given":"D.","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,2]]},"reference":[{"issue":"3","key":"2050_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40142-016-0100-7","volume":"4","author":"WE Tidyman","year":"2016","unstructured":"Tidyman WE, Rauen KA. Expansion of the RASopathies. Curr Genet Med Rep. 2016;4(3):57\u201364. https:\/\/doi.org\/10.1007\/s40142-016-0100-7.","journal-title":"Curr Genet Med Rep"},{"key":"2050_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ajmg.a.31017","volume":"139A","author":"E Lopez-Rangel","year":"2005","unstructured":"Lopez-Rangel E, Malleson PN, Lirenman DS, Roa B, Wiszniewska J, Lewis ME. Systemic Lupus Erythematous and other autoimmune disorders in children with Noonan Syndrome. Am J Med Genet Part A. 2005;139A:239\u201342.","journal-title":"Am J Med Genet Part A"},{"key":"2050_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.smim.2006.03.013","volume":"18","author":"T Mustelin","year":"2006","unstructured":"Mustelin T. Are other protein tyrosine phosphatases than PTPN22 associated with autoimmunity? Semin Immunol. 2006;18:254\u201360.","journal-title":"Semin Immunol"},{"key":"2050_CR4","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1042\/BST0340858","volume":"34","author":"JC Stone","year":"2006","unstructured":"Stone JC. Regulation of Ras in lymphocytes: get a GRP. Biochem Soc Trans. 2006;34:858\u201361.","journal-title":"Biochem Soc Trans"},{"key":"2050_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/08916930701464897","volume":"40","author":"T Vang","year":"2007","unstructured":"Vang T, Miletic AV, Bottini N, Mustelin T. Protein tyrosine phosphatase in human autoimmunity. Autoimmunity. 2007;40:453\u201361.","journal-title":"Autoimmunity"},{"key":"2050_CR6","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.425","volume":"41","author":"V Cordeddu","year":"2009","unstructured":"Cordeddu V, Di Schiavi E, Pennacchio LA, Ma\u2019ayan A, Sarkozy A, Fodale V, et al. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat Genet. 2009;41:1022\u20136.","journal-title":"Nat Genet"},{"key":"2050_CR7","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1002\/ajmg.a.37781","volume":"170","author":"KW Gripp","year":"2016","unstructured":"Gripp KW, Aldinger KA, Bennett JT, Baker L, Tusi J, Powell-Hamilton N, et al. A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair. Am J Med Genet Part A. 2016;170:2237\u201347.","journal-title":"Am J Med Genet Part A"},{"key":"2050_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1086\/499925","volume":"78","author":"M Tartaglia","year":"2006","unstructured":"Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, et al. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet. 2006;78:279\u201390.","journal-title":"Am J Hum Genet"},{"key":"2050_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ajmg.a.36842","volume":"167A","author":"E Nishi","year":"2015","unstructured":"Nishi E, Mizuno S, Nanjo Y, Niihori T, Fukushima Y, Matsubara Y, et al. A novel heterozygous MAP2K1 mutation in a patient with Noonan syndrome with multiple lentigines. Am J Med Genet Part A. 2015;167A:407\u201311.","journal-title":"Am J Med Genet Part A"},{"key":"2050_CR10","doi-asserted-by":"crossref","unstructured":"Tidyman, WE.; Rauen, KA. Molecular cause of cardio-facio-cutaneous syndrome. In: Zenker, M., editor. Noonan syndrome and related disorders: a matter of deregulated ras signaling. Monogr Hum Genet. 17. Basel, Switz: Karger; 2009. p. 73\u201382.","DOI":"10.1159\/000164843"},{"key":"2050_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ajhg.2013.05.021","volume":"93","author":"Y Aoki","year":"2013","unstructured":"Aoki Y, Niihori T, Banjo T, Okamoto N, Mizuno S, Kurosawa K, et al. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS\/MAPK pathway syndrome. Am J Hum Genet. 2013;93:173\u201380.","journal-title":"Am J Hum Genet"},{"key":"2050_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","volume":"14","author":"KA Rauen","year":"2013","unstructured":"Rauen KA. The RASopathies. Annu Rev Genomics Hum Genet. 2013;14:355\u201369. https:\/\/doi.org\/10.1146\/annurev-genom-091212-153523.","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"18","key":"2050_CR13","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood-2014-11-567917","volume":"125","author":"KR Calvo","year":"2015","unstructured":"Calvo KR, Price S, Braylan RC, Oliveira JB, Lenardo M, Fleisher TA, Rao VK. JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities. Blood. 2015;125(18):2753\u20138. https:\/\/doi.org\/10.1182\/blood-2014-11-567917.","journal-title":"Blood"},{"issue":"1","key":"2050_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/s1054-139x(02)00364-6","volume":"32","author":"A Amoroso","year":"2003","unstructured":"Amoroso A, Garzia P, Vadacca M, et al. The unusual association of three autoimmune diseases in a patient with Noonan syndrome. J Adolesc Health. 2003;32(1):94\u20137. https:\/\/doi.org\/10.1016\/s1054-139x(02)00364-6.","journal-title":"J Adolesc Health"},{"issue":"5","key":"2050_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/ajcp\/95.5.739","volume":"95","author":"JT Flick","year":"1991","unstructured":"Flick JT, Singh AK, Kizer J, Lazarchick J. Platelet dysfunction in Noonan\u2019s syndrome. A case with a platelet cyclooxygenase-like deficiency and chronic idiopathic thrombocytopenic purpura. Am J Clin Pathol. 1991;95(5):739\u201342. https:\/\/doi.org\/10.1093\/ajcp\/95.5.739.","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2050_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejmg.2014.12.013","volume":"58","author":"I Loddo","year":"2015","unstructured":"Loddo I, Romano C, Cutrupi MC, et al. Autoimmune liver disease in Noonan Syndrome. Eur J Med Genet. 2015;58(3):188\u201390. https:\/\/doi.org\/10.1016\/j.ejmg.2014.12.013.","journal-title":"Eur J Med Genet"},{"issue":"5","key":"2050_CR17","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/ajmg.a.35290","volume":"158A","author":"CR Quaio","year":"2012","unstructured":"Quaio CR, Carvalho JF, da Silva CA, Bueno C, Brasil AS, Pereira AC, Jorge AA, Malaquias AC, Kim CA, Bertola DR. Autoimmune disease and multiple autoantibodies in 42 patients with RASopathies. Am J Med Genet A. 2012;158A(5):1077\u201382. https:\/\/doi.org\/10.1002\/ajmg.a.35290 (Epub 2012 Apr 9).","journal-title":"Am J Med Genet A"},{"key":"2050_CR18","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"2050_CR19","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Burroughs AK, Cancado EL, Chapman RW, Cooksley WGE, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston ALWF, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RNM, Maddrey WC, Manns MP, McFarlane IG, Meyer Zum Buschenfelde KH, Mieli-Vergani G, Nakanuma Y, Nishioka M, Penner E, Porta G, Portmann BC, Reed WD, Rodes J, Schalm SW, Scheuer PJ, Schrumpf E, Seki T, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniyaet M. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929\u201338.","journal-title":"J Hepatol"},{"key":"2050_CR20","first-page":"27","volume":"33","author":"JA Franklyn","year":"2005","unstructured":"Franklyn JA. Hypothyroidism Med. 2005;33:27\u20139.","journal-title":"Hypothyroidism Med"},{"key":"2050_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295\u2013306.","journal-title":"J Thromb Haemost"},{"key":"2050_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/0378-6323.32708","volume":"73","author":"VN Sehgal","year":"2007","unstructured":"Sehgal VN, Srivastava G. Vitiligo: Compendium of clinicoepidemilogical features. Indian J Dermatol Venereol Leprol. 2007;73:149\u201356.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2050_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1210\/jc.2007-2134","volume":"93","author":"CE De Block","year":"2008","unstructured":"De Block CE, De Leeuw IH, Van Gaal LF. Autoimmune gastritis in type 1 diabetes: a clinically oriented review. J Clin Endocrinol Metab. 2008;93:363\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"2050_CR24","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.amjmed.2010.02.019","volume":"123","author":"C Catassi","year":"2010","unstructured":"Catassi C, Fasano A. Celiac disease diagnosis: Simple rules are better than complicated algorithms. Am J Med. 2010;123:691\u20133.","journal-title":"Am J Med"},{"key":"2050_CR25","unstructured":"Ugazio AG et al Il bambino immunodepresso: perch\u00e9 lo \u00e8 e come va difeso. CEA, 1995"},{"key":"2050_CR26","unstructured":"La linfopenia nel bambino. C. Dallavilla, R. Badolato. Medico e Bambino 2015;34:239\u2013246."},{"key":"2050_CR27","first-page":"6236","volume":"159","author":"Primary Immunodeficiency Diseases","year":"1997","unstructured":"Primary Immunodeficiency Diseases. Report of a WHO Scientific Group WHO. Clin Exp Immunol. 1997;159:6236\u201341.","journal-title":"Clin Exp Immunol"},{"key":"2050_CR28","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2119\/molmed.2011.00195","volume":"17","author":"N Wang","year":"2011","unstructured":"Wang N, Shen N, Vyse TJ, et al. Selective IgA deficiency in autoimmune diseases. Mol Med. 2011;17:1383.","journal-title":"Mol Med"},{"issue":"2","key":"2050_CR29","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1016\/j.jaci.2004.12.652","volume":"115","author":"RW Hostoffer","year":"2005","unstructured":"Hostoffer RW, Macleish S. Noonan\u2019s syndrome associated with hypogamma \u2013globulinemia. J Allergy Clin Immunol. 2005;115(2):S160.","journal-title":"J Allergy Clin Immunol"},{"key":"2050_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/1096-8628(20010722)102:1<59::AID-AJMG1351>3.0.CO;2-O","volume":"102","author":"DM Martin","year":"2001","unstructured":"Martin DM, Gencyuz CF, Petty EM. Systemic lupus erythematosus in a man with Noonan syndrome. Am J Med Genet. 2001;102:59\u201362.","journal-title":"Am J Med Genet"},{"key":"2050_CR31","first-page":"181","volume":"12","author":"MS Berberich","year":"1976","unstructured":"Berberich MS, Hall JG. Noonan syndrome-an unusual family with above average intelligence, a high incidence of cancer and rare type of vasculitis. Birth Defects Orig Artic Ser. 1976;12:181\u20136.","journal-title":"Birth Defects Orig Artic Ser"},{"key":"2050_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/01.mcd.0000127467.04018.6d","volume":"13","author":"Y Alanay","year":"2004","unstructured":"Alanay Y, Balc S, Ozen S. Noonan syndrome and systemic lupus erythematosus: presentation in childhood. Clin Dysmorphol. 2004;13:161\u20133.","journal-title":"Clin Dysmorphol"},{"key":"2050_CR33","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.pediatrneurol.2004.05.015","volume":"31","author":"Y Yamashita","year":"2004","unstructured":"Yamashita Y, Kusaga A, Koga Y, Nagamitsu S, Matsuishi T. Noonan syndrome, moyamoya-like vascular changes, and antiphospholipid syndrome. Pediatr Neurol. 2004;31:364\u20136.","journal-title":"Pediatr Neurol"},{"key":"2050_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1515\/JPEM.2003.16.2.217","volume":"16","author":"J Svensson","year":"2003","unstructured":"Svensson J, Carlsson A, Ericsson UB, Westphal O, Ivarsson SA. Noonan\u2019s syndrome and autoimmune diseases. J Pediatr Endocrinol Metab. 2003;16:217\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2050_CR35","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.autrev.2007.01.006","volume":"6","author":"N Bizzaro","year":"2007","unstructured":"Bizzaro N. Autoantibodies as predictors of disease: the clinical and experimental evidence. Autoimmun Rev. 2007;6:325\u201333.","journal-title":"Autoimmun Rev"},{"key":"2050_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jaut.2013.06.004","volume":"45","author":"DM Gravano","year":"2013","unstructured":"Gravano DM, Hoyer KK. Promotion and prevention of autoimmune disease by CD8+ T cells. J Autoimmun. 2013;45:68\u201379.","journal-title":"J Autoimmun"},{"key":"2050_CR37","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3389\/fimmu.2019.00856","volume":"10","author":"Q Deng","year":"2019","unstructured":"Deng Q, Luo Y, Chang C, Wu H, Ding Y, Xiao R. The emerging epigenetic role of CD8+T cells in autoimmune diseases: a systematic review. Front Immunol. 2019;10:856.","journal-title":"Front Immunol"},{"key":"2050_CR38","first-page":"189096","volume":"2012","author":"MP Pender","year":"2012","unstructured":"Pender MP. CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis. Autoimmune Dis. 2012;2012:189096.","journal-title":"Autoimmune Dis"},{"issue":"11","key":"2050_CR39","doi-asserted-by":"publisher","first-page":"7617","DOI":"10.4049\/jimmunol.181.11.7617","volume":"181","author":"WN D'Souza","year":"2008","unstructured":"D\u2019Souza WN, Chang CF, Fischer AM, Li M, Hedrick SM. The Erk2 MAPK regulates CD8 T cell proliferation and survival. J Immunol. 2008;181(11):7617\u201329.","journal-title":"J Immunol"},{"key":"2050_CR40","first-page":"4810258","volume":"2017","author":"Q Guan","year":"2017","unstructured":"Guan Q, Zhang J. Recent advances: the imbalance of cytokines in the pathogenesis of inflammatory bowel disease. Mediators Inflamm. 2017;2017:4810258.","journal-title":"Mediators Inflamm"},{"issue":"4\u20135","key":"2050_CR41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S1359-6101(02)00018-7","volume":"13","author":"ET Andreakos","year":"2002","unstructured":"Andreakos ET, Foxwell BM, Brennan FM, Maini RN, Feldmann M. Cytokines and anti-cytokine biologicals in autoimmunity: present and future. Cytokine Growth Factor Rev. 2002;13(4\u20135):299\u2013313.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"2050_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1521-6616(03)00145-1","volume":"108","author":"RR Singh","year":"2003","unstructured":"Singh RR. IL-4 and many roads to lupuslike autoimmunity. Clin Immunol. 2003;108(2):73\u20139.","journal-title":"Clin Immunol"},{"issue":"1","key":"2050_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/TP.0000000000001452","volume":"101","author":"SC Jordan","year":"2017","unstructured":"Jordan SC, Choi J, Kim I, Wu G, Toyoda M, Shin B, Vo A. Interleukin-6, A cytokine critical to mediation of inflammation, autoimmunity and allograft rejection: therapeutic implications of IL-6 receptor blockade. Transplantation. 2017;101(1):32\u201344.","journal-title":"Transplantation"},{"issue":"25","key":"2050_CR44","doi-asserted-by":"publisher","first-page":"eaat1482","DOI":"10.1126\/sciimmunol.aat1482","volume":"3","author":"AK Abbas","year":"2018","unstructured":"Abbas AK, Trotta E, Simeonov DR, Marson A, Bluestone JA. Revisiting IL-2: Biology and therapeutic prospects. Sci Immunol. 2018;3(25):eaat1482.","journal-title":"Sci Immunol"},{"issue":"1","key":"2050_CR45","doi-asserted-by":"publisher","first-page":"e20190418","DOI":"10.1084\/jem.20190418","volume":"217","author":"M Saraiva","year":"2020","unstructured":"Saraiva M, Vieira P, O\u2019Garra A. Biology and therapeutic potential of interleukin-10. J Exp Med. 2020;217(1):e20190418.","journal-title":"J Exp Med"},{"key":"2050_CR46","doi-asserted-by":"crossref","unstructured":"Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER et al. Pediatric AIDS Clinical Trials Group. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112(5):973\u201380.","DOI":"10.1016\/j.jaci.2003.07.003"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-02050-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T15:07:18Z","timestamp":1633360038000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02050-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2050"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-02050-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,2]]},"assertion":[{"value":"26 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible Institutional Committee on Human Experimentation and with the Helsinki Declaration of 1975 (revised in 2000). The study was approved by the Ethics Committee of the University Hospital of Salerno.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was written by the parents of patients to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"410"}}